Hazard Information | Back Directory | [Description]
UE2343 (Xanamem) is a potent, orally bioavailable, brain-penetrant 11β-HSD1 inhibitor. | [Uses]
UE2343 is an orally available, brain-penetrant 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor. UE2343 is being investigated for the treatment of Alzheimer's disease[1]. | [References]
[1] Webster S P, et al. Selection and early clinical evaluation of the brain‐penetrant 11β‐hydroxysteroid dehydrogenase type 1 (11β‐HSD1) inhibitor UE2343 (Xanamem?)[J]. British Journal of Pharmacology, 2017, 174(5): 396-408. DOI:10.1111/bph.13699 |
|
Company Name: |
mahaloong
|
Tel: |
+86-028-81192082 +86-18180560816 |
Website: |
https://www.mahaloong.com |
Company Name: |
Biorbyt Ltd.
|
Tel: |
+44 (0)1223 859 353 |
Website: |
http://www.biorbyt.com |
|